Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 147

1.

Mitochondrial retrograde signaling induces epithelial-mesenchymal transition and generates breast cancer stem cells.

Guha M, Srinivasan S, Ruthel G, Kashina AK, Carstens RP, Mendoza A, Khanna C, Van Winkle T, Avadhani NG.

Oncogene. 2014 Nov 6;33(45):5238-50. doi: 10.1038/onc.2013.467. Epub 2013 Nov 4.

2.

The mitotic kinase Aurora--a promotes distant metastases by inducing epithelial-to-mesenchymal transition in ERα(+) breast cancer cells.

D'Assoro AB, Liu T, Quatraro C, Amato A, Opyrchal M, Leontovich A, Ikeda Y, Ohmine S, Lingle W, Suman V, Ecsedy J, Iankov I, Di Leonardo A, Ayers-Inglers J, Degnim A, Billadeau D, McCubrey J, Ingle J, Salisbury JL, Galanis E.

Oncogene. 2014 Jan 30;33(5):599-610. doi: 10.1038/onc.2012.628. Epub 2013 Jan 21.

3.

Nicastrin regulates breast cancer stem cell properties and tumor growth in vitro and in vivo.

Lombardo Y, Filipović A, Molyneux G, Periyasamy M, Giamas G, Hu Y, Trivedi PS, Wang J, Yagüe E, Michel L, Coombes RC.

Proc Natl Acad Sci U S A. 2012 Oct 9;109(41):16558-63. doi: 10.1073/pnas.1206268109. Epub 2012 Sep 24.

4.

High mitochondrial DNA copy number and bioenergetic function are associated with tumor invasion of esophageal squamous cell carcinoma cell lines.

Lin CS, Lee HT, Lee SY, Shen YA, Wang LS, Chen YJ, Wei YH.

Int J Mol Sci. 2012;13(9):11228-46. doi: 10.3390/ijms130911228. Epub 2012 Sep 10.

5.

Notch1 signaling regulates the epithelial-mesenchymal transition and invasion of breast cancer in a Slug-dependent manner.

Shao S, Zhao X, Zhang X, Luo M, Zuo X, Huang S, Wang Y, Gu S, Zhao X.

Mol Cancer. 2015 Feb 3;14:28. doi: 10.1186/s12943-015-0295-3.

6.

Cell signaling by urokinase-type plasminogen activator receptor induces stem cell-like properties in breast cancer cells.

Jo M, Eastman BM, Webb DL, Stoletov K, Klemke R, Gonias SL.

Cancer Res. 2010 Nov 1;70(21):8948-58. doi: 10.1158/0008-5472.CAN-10-1936. Epub 2010 Oct 12.

7.

Combinatorial TGF-β attenuation with paclitaxel inhibits the epithelial-to-mesenchymal transition and breast cancer stem-like cells.

Park SY, Kim MJ, Park SA, Kim JS, Min KN, Kim DK, Lim W, Nam JS, Sheen YY.

Oncotarget. 2015 Nov 10;6(35):37526-43. doi: 10.18632/oncotarget.6063.

8.

Epithelial-mesenchymal transition and cancer stem cells: a dangerously dynamic duo in breast cancer progression.

May CD, Sphyris N, Evans KW, Werden SJ, Guo W, Mani SA.

Breast Cancer Res. 2011 Feb 8;13(1):202. doi: 10.1186/bcr2789. Review.

9.

FOXC2 expression links epithelial-mesenchymal transition and stem cell properties in breast cancer.

Hollier BG, Tinnirello AA, Werden SJ, Evans KW, Taube JH, Sarkar TR, Sphyris N, Shariati M, Kumar SV, Battula VL, Herschkowitz JI, Guerra R, Chang JT, Miura N, Rosen JM, Mani SA.

Cancer Res. 2013 Mar 15;73(6):1981-92. doi: 10.1158/0008-5472.CAN-12-2962. Epub 2013 Feb 1.

10.

CDKL2 promotes epithelial-mesenchymal transition and breast cancer progression.

Li L, Liu C, Amato RJ, Chang JT, Du G, Li W.

Oncotarget. 2014 Nov 15;5(21):10840-53.

11.

Mitochondrial dysfunction accounts for aldosterone-induced epithelial-to-mesenchymal transition of renal proximal tubular epithelial cells.

Yuan Y, Chen Y, Zhang P, Huang S, Zhu C, Ding G, Liu B, Yang T, Zhang A.

Free Radic Biol Med. 2012 Jul 1;53(1):30-43. doi: 10.1016/j.freeradbiomed.2012.03.015. Epub 2012 Apr 25.

PMID:
22608985
12.

Activation-induced cytidine deaminase (AID) is necessary for the epithelial-mesenchymal transition in mammary epithelial cells.

Muñoz DP, Lee EL, Takayama S, Coppé JP, Heo SJ, Boffelli D, Di Noia JM, Martin DI.

Proc Natl Acad Sci U S A. 2013 Aug 6;110(32):E2977-86. doi: 10.1073/pnas.1301021110. Epub 2013 Jul 23.

13.

TGF-β-Id1 signaling opposes Twist1 and promotes metastatic colonization via a mesenchymal-to-epithelial transition.

Stankic M, Pavlovic S, Chin Y, Brogi E, Padua D, Norton L, Massagué J, Benezra R.

Cell Rep. 2013 Dec 12;5(5):1228-42. doi: 10.1016/j.celrep.2013.11.014.

14.

Targeting ROR1 inhibits epithelial-mesenchymal transition and metastasis.

Cui B, Zhang S, Chen L, Yu J, Widhopf GF 2nd, Fecteau JF, Rassenti LZ, Kipps TJ.

Cancer Res. 2013 Jun 15;73(12):3649-60. doi: 10.1158/0008-5472.CAN-12-3832.

15.

Notch1 induces epithelial-mesenchymal transition and the cancer stem cell phenotype in breast cancer cells and STAT3 plays a key role.

Zhang X, Zhao X, Shao S, Zuo X, Ning Q, Luo M, Gu S, Zhao X.

Int J Oncol. 2015 Mar;46(3):1141-8. doi: 10.3892/ijo.2014.2809. Epub 2014 Dec 23.

PMID:
25544568
16.

miR-300 inhibits epithelial to mesenchymal transition and metastasis by targeting Twist in human epithelial cancer.

Yu J, Xie F, Bao X, Chen W, Xu Q.

Mol Cancer. 2014 May 24;13:121. doi: 10.1186/1476-4598-13-121.

17.

MiR-373 drives the epithelial-to-mesenchymal transition and metastasis via the miR-373-TXNIP-HIF1α-TWIST signaling axis in breast cancer.

Chen D, Dang BL, Huang JZ, Chen M, Wu D, Xu ML, Li R, Yan GR.

Oncotarget. 2015 Oct 20;6(32):32701-12. doi: 10.18632/oncotarget.4702.

18.

SOX4 induces epithelial-mesenchymal transition and contributes to breast cancer progression.

Zhang J, Liang Q, Lei Y, Yao M, Li L, Gao X, Feng J, Zhang Y, Gao H, Liu DX, Lu J, Huang B.

Cancer Res. 2012 Sep 1;72(17):4597-608. doi: 10.1158/0008-5472.CAN-12-1045. Epub 2012 Jul 11.

19.

Fucoidan induces changes in the epithelial to mesenchymal transition and decreases metastasis by enhancing ubiquitin-dependent TGFβ receptor degradation in breast cancer.

Hsu HY, Lin TY, Hwang PA, Tseng LM, Chen RH, Tsao SM, Hsu J.

Carcinogenesis. 2013 Apr;34(4):874-84. doi: 10.1093/carcin/bgs396. Epub 2012 Dec 28.

PMID:
23275155
20.

XBP1 induces snail expression to promote epithelial- to-mesenchymal transition and invasion of breast cancer cells.

Li H, Chen X, Gao Y, Wu J, Zeng F, Song F.

Cell Signal. 2015 Jan;27(1):82-9. doi: 10.1016/j.cellsig.2014.09.018. Epub 2014 Oct 2.

PMID:
25280941

Supplemental Content

Support Center